Global research trends on anti-pd-1/anti-pd-l1 immunotherapy for triple-negative breast cancer: a scientometric analysis

HIGHLIGHTS

SUMMARY

    In 2020, breast cancer (BC) overtook lung cancer in women as the most frequently diagnosed cancer, with an estimated 2.3 million new cases (11.7%) and 684,996 deaths (6.9%). Triple-negative breast cancer (TNBC), the absence of expression of ER, PR, and HER2, is an extremely aggressive and heterogeneous tumor, accounting for 15%-20% of all breast cancer cases. Compare with other types of cancer, breast cancer has a lower number of tumor-infiltrating immune system_cells with tumor-rejecting capacity (primarily T lymphocytes). Abbreviations: TNBC, triple-negative breast cancer; BC, breast . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?